TY - GEN 
AU - Garzon V
AU - Salvador J.-P
AU - Marco M.-P
AU - G.-Pinacho D
AU - Bustos R.-H.
PY - 2024
SN - 20796382
UR - http://hdl.handle.net/10818/61939
AB - More than 70% of bacteria are resistant to all or nearly all known antimicrobials, creating the need for the development of new types of antimicrobials or the use of “last-line” antimicrobial therapies for the treatment of multi-resistant bacteria....
LA - eng
PB - Antibiotics
KW - Antibiotics
KW - Antibodies
KW - Antimicrobial resistance (Amr)
KW - Colistin
KW - Daptomycin
KW - Elisa
KW - Meropenem
KW - Vancomycin
TI - Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach
DO - 10.3390/antibiotics13070600
ER -